“Cannabis in the News: Curaleaf TSX Listing, STATES Act Revival

As states within the US take steps to embrace cannabis reforms, the industry is benefitting from new opportunities in the stock market. Curaleaf Holdings Inc. (CUR.N) is hoping to make their TSX listing by archiving record highs during their latest earnings. The multi-state cannabis operator, based in Wakefield, Mass., reported a 117% year-over-year lead to $126.7 million for the four-quarter ending on June 30th, 2020. This surge in growth includes quality organic sales, as well as consolidation by buying out smaller cannabis companies. Shares are up 140% percent since the beginning of 2020, and provide a much needed choice for investors who are looking to support the blossoming industry. The company’s focus is on providing medical marijuana to easily accessible locations. Despite this, they have been able to jump 31 spots in the U.S. Marijuana Index after two quarter-end reports. Additionally, Curaleaf has now inquired for a listing on the Toronto Stock Exchange, which puts them solidly in view of becoming much more accessible to the North American investment sector. While it seems like some of the biggest issues with state cannabis reform has been sorted out, there is still more to be done in other states. California managed to meet $0.4 billion in sales since implementing “track and trace” regulations last summer. Colorado has also seen a surge in sales, although there are reports of overstocking problems that have lead to shortages in the recreational system. Overall, the cannabis industry is slowly gaining ground in both the US and Canadian investment markets. With the TSX listing of Curaleaf, investor confidence in the sector is sure to rise in the coming quarters. It remains to be seen whether other companies will be motivated to do the same and whether this could spell success for the industry in the long run. As states within the US take steps to embrace cannabis reforms, the industry is benefitting from new opportunities in the stock market. Curaleaf Holdings Inc. (CUR.N) is hoping to make their TSX listing by archiving record highs during their latest earnings. The multi-state cannabis operator, based in Wakefield, Mass., reported a 117% year-over-year lead to $126.7 million for the four-quarter ending on June 30th, 2020. This surge in growth includes quality organic sales, as well as consolidation by buying out smaller cannabis companies. Shares are up 140% percent since the beginning of 2020, and provide a much needed choice for investors who are looking to support the blossoming industry. The company’s focus is on providing medical marijuana to easily accessible locations. Despite this, they have been able to jump 31 spots in the U.S. Marijuana Index after two quarter-end reports. Additionally, Curaleaf has now inquired for a listing on the Toronto Stock Exchange, which puts them solidly in view of becoming much more accessible to the North American investment sector. While it seems like some of the biggest issues with state cannabis reform has been sorted out, there is still more to be done in other states. California managed to meet $0.4 billion in sales since implementing “track and trace” regulations last summer. Colorado has also seen a surge in sales, although there are reports of overstocking problems that have lead to shortages in the recreational system. Overall, the cannabis industry is slowly gaining ground in both the US and Canadian investment markets. With the TSX listing of Curaleaf, investor confidence in the sector is sure to rise in the coming quarters. It remains to be seen whether other companies will be motivated to do the same and whether this could spell success for the industry in the long run.